Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials
European Journal of Cancer2015Vol. 51(13), pp. 1742–1750
Citations Over TimeTop 1% of 2015 papers
Tjalling Bosse, Elke E.M. Peters, Carien L. Creutzberg, Ina M. Jürgenliemk‐Schulz, Jan J. Jobsen, Jan Willem Mens, Ludy Lutgens, Elzbieta M. van der Steen‐Banasik, Vincent T.H.B.M. Smit, Remi A. Nout
Related Papers
- → A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer(2014)88 cited
- → Pharmacologic Sensitivity of Paclitaxel to Its Delivery Vehicles Drives Distinct Clinical Outcomes of Paclitaxel Formulations(2015)44 cited
- Pharmacokinetics of paclitaxel in a hemodialysis patient with advanced gastric cancer： A case report(2006)
- → Synthesis and biological activity of A-nor-paclitaxel analogues(1997)14 cited
- Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients(2006)